Technical
EUR JPY TECHHello Everybody. Hello TradingView.
This is Technical Analysis for the pair EUR/JPY Let's Start!
In BigPicture price is going up well. It's not a selling area or something.
As you see Price is going up to check the resistance level on top of the channel.
Also, we got very nice support on 128.090!
My Position is going long for +70 +80 Pips. :)
You can think about making more using this position. (situation).
Well. If you have any questions? Tell me everything.
If you don't agree to explain to me why and let's talk about it.
Here is FxCROWN
Thank You For Your Time
XAUUSD WEEKLY, AT CRITICAL LEVEL, BELOW 1877 TESTING 1835XAUUSD formed candlestick pattern: Long Upper Shadow, Bearish Signal.
Break & Hold Below 1877, Cancel Bullish Medium Term Outlook. Turned to Neutral. Potentially Testing 1835 (MA 50 & 100 W) & 1785.
As a reference, You can also see my XAUUSD H1 bearish outlook www.tradingview.com
ABOVE 1660, BUY ON WEAKNESS.
Break & Hold Above 1998, Bullish Medium Term Outlook Resume.
Break & Hold Below 1660, Bearish Medium Term Outlook. But,
LONG TERM OUTLOOK STILL BULLISH !
Advanced Channel (SeaWorld, Daily)This isn't a direct trade, however the channel highs and lows can be traded by analyzing the candlestick patterns from those levels and trading accordingly. This is more for learning about how to draw channels. The dark channel lines are the main reversal level. The dashed line is the minor level of the channel. The green area is the buy zone. And the pink area is the sell zone. You can see how accurate this particular channel has been in containing prices. You look to sell at the channel highs and buy at the channel lows. Hope this helps someone.
SHIBUSDT long postion Possibilityhello every one
this is a technical analysis for Shib and you know every time shiba inu fall this area rise up
so i think next target will be 28
all you need to know is in the chart
look closely and make your position smartly
this is just my idea and not a financial advice
Technical analysis on PROGProgenity Inc. (NASDAQ: PROG) is a biotechnology company that develops and commercializes molecular testing products to improve the diagnosis and treatment of disease. It focuses on fields like women’s health, gastrointestinal health, and oral biotherapeutics. Now trading at $.88, PROG stock, was one of the best penny stocks on robinhood last year despite dropping from its IPO price of $14 per share to below $1. This was largely because it became one of the most popular reddit penny stocks in September – triggering a roughly 518% rally for PROG stock. On the verge of changing its name to Biora Therapeutics (NASDAQ: BIOR), BIOR stock is now one of the cheapest penny stocks on Robinhood 2022.
PROG stock price is currently $.90 – a new low for 2022. As the stock trades at its strong support level of $.85 formed in September 2021, its next level of support would be near $.65. However, its trend to the downside could indicate a rebound off of this strong support level and back to its weak resistance at roughly $1. Overall, PROG stock has no clear resistance and could push past $1 with a strong catalyst. The stock has a gap to fill between $1.50 and $1.58 which was created in the sell off at earnings.
The RSI is moving up from 53 and the MACD is bearish but approaching a crossover. Meanwhile, accumulation which was climbing at the start of April is slowly decreasing.
Bior Stock Short Interest & Options Flow
At the moment, short interest is 14.8% of the float but its off exchange short volume ratio is 49.97%. The current short volume of 20.65 million is almost equal to its volume at the end of October when its initial run up began. With 2.3 days to cover, many investors believe something could be brewing for BIOR stock ahead of its earnings report.
Using @unusualwhales option flow, its clear that bears are the majority. Despite call volume coming in at 95%, bearish premiums win out at 64.06%. Two whales bought puts with $17 thousand premiums with a far out expiration date of January 19th, 2024. Since BIOR stock is currently trading below $1 its not surprising that the options flow is showing little activity.
Considering its current low volume of 2.6 million it seems unlikely that a major announcement is expected in May. However some investors believe that a merger could be coming soon since the company brought Paul Shabram on board to lead Technical Operations for BIOR’s ingestible drug and device platforms – a move that hints at the applicability of BIOR’s DDS and OBDS to major pharmaceutical companies.
BIOR Stock Forecast
While BIOR missed earnings expectations with an EPS loss of $.56 – $.40 more than analyst expectations – its revenue was $185 thousand more than expected. In light of this, its sell of following earnings could be unnatural. Given its float of 165.4 million, the stock is prone to volatility and depending on the results of its earnings report in May, the stock could gain back some of the ground it lost. Overall, the stock’s current price is much lower than average and a correction could be due.
As is, Progenity has a market cap of $157 million, which could make it undervalued given its technology’s potential once commercialized. In the long term, BIOR has the potential for a buyout from a major pharma company like Pfizer, which could results in a major return on investment for shareholders. On the other hand, its technologies’ range of applications could lead BIOR to become a profitable pill manufacturer once its DDS or OBDS systems are approved.
Despite its IPO price of $15 per share, BIOR stock has been treading water for a while which is typical of clinical-stage biotech plays that move on binary events like FDA approval. Its worth noting that Raymond James analysts have lowered their price target from $55 to $42 for the stock which is a modest decrease considering the firm’s growth expectations for the company in the long term.
Technical analysis on HCDIAs a real estate developer and home builder, Harbor Custom Development, Inc. (NASDAQ: HCDI) acquires and develops lands with scenic views to build its housing projects in Washington, California, Texas, and Florida. After listing some of its Washington projects for $278 million, HCDI stock has seen a surge in trading volume. With a volume of 24.9 million over the past week – a massive increase from its average daily volume of 464 thousand shares – HCDI stock increased 44% overnight. Considering its high short interest and high trading volume, many investors are speculating HCDI stock could be a short squeeze candidate.
Currently trading at $2.60, HCDI stock shows a weak support at 2.40 and a weak resistance at 2.66. After HCDI stock’s initial run-up, accumulation took a hit as bag holders left their positions. Currently the MACD is bearish but could be approaching a bullish crossover while the RSI is at 55 after earlier overbuying.
Given the company’s solid share structure of 13.2 million OS and its extremely low float of 9.1 million, could continue to move up on momentum. Currently one of the best short squeeze candidates, HCDI stock could continue its run but entering a position at this time presents considerable risk.
Stock Repurchase
Another pending catalyst for HCDI stock is the company’s stock repurchase program which will allow the company to repurchase up to $5 million worth of the company’s outstanding shares through May 2022. HCDI’s management intends to retire these shares and return them to its unissued shares. This move will reduce the company’s OS by 17% – leaving HCDI stock with only 11.21 million shares outstanding at its current PPS of $2.48. Considering that HCDI already has a low float of 9.1 million shares, this move improves the stock’s long-term outlook.
Short Squeeze
Despite all of these catalysts, investors are taking notice of HCDI stock due to its short squeeze potential. Since listing its units for $278 million, HCDI stock has been witnessing unusually high trading volume – leading to a 44% surge. According to Fintel data, HCDI stock’s short interest is 23.88% and there are no available shares to short. As a result, HCDI stock could continue its run while swing traders potentially hold the stock for HCDI’s Q1 earnings report on May 12th.
HCDI Stock Forecast
After increasing its real estate assets by 500% in 2021, HCDI is beginning to realize revenues from these investments. With the company selling a six-acre multi-family lot for $4.48 million and offering 734 units for $278 million, HCDI is on track to deliver on its promise of $160 million in revenues for 2022. As more and more projects are offered for sale, many investors believe HCDI stock could be a profitable long-term hold.
However macroeconomic trends such as the Federal Reserve’s interest rate hikes will likely put a damper on home buying activity since mortgage rates are already increasing. These higher payment will impact homebuyers and is likely one reason why short sellers have taken an interest in HCDI.
On the other hand, housing is a need regardless of the market. Given HCDI’s focus on the red hot housing markets of Seattle and Austin, the company could weather the storm and prove to be a profitable long-term hold for investors willing to take the risk. Regardless of these long-term trends, HCDI stock is likely one to watch for its short squeeze potential the next few weeks.
Technical analysis on KATXDrawing to the close of its custodianship, Kat Exploration Inc (OTC: KATX) has been building on anticipation for the termination of its custodianship – currently schedule for May 11th. Following the release of its quarterly and annual reports, KATX stock saw a roughly 458% run over two weeks. Now, investors are waiting on impending merger news for this clean shell.
KATX stock is currently trading at $.0058 – near its resistance at .006. Meanwhile it shows a support at .005 and a secondary support at .0045. The MACD is bullish while the RSI moves up from 51.08. Accumulation has been holding steady following KATX’s run up.
Given its impending catalyst, bullish investors could potentially add shares near $.005 as anticipation builds for the custodianship termination on May 11th. But KATX stock is likely one to watch beyond that for news of its merger. With a market cap of $10.4 million, the stock could be cheap at these levels depending on the merging company.
BitCoke Token, the bottom is here and may get 20% pumpBitCoke token COKE is a new comer in the field of platform token. As the native token of BitCoke, like other competing exchange tokens, it functions as an utility token, whose holders exclusively receive a set of benefits and privileges.
Despite growing adoption cases and user numbers, COKE price has gone through a dramatic fall since the end of previous launchpad IEO. The close to 50% plunge may be attribute to a couple of reasons, like the weak broad crypto market, high inflation, interest hike from Fed, and so forth. Specifically, once the launchpad subscription ended, the locked COKE tokens become circulating, resulting in high selling pressure on the price.
This week, the price has appered to bottom around $0.8 - 0.9 range as we multiple lower-wick bars, indicting possible strong demand from the buy side. Even though the price movement over the last 2 weeks looks volatile and disorganized, the overall strucutre looks like a parallel channel in 4 hour timeframe. From the technical standpoint, this is a bullish sigal and the price will eventually break out somewhere at the channel. Besides, one must keep in mind that BitCoke, like most exchanges, have launchpad platform for new token funding. As a rule of thumb, in order to subscribe the new token, its users are required to commit COKE to get allocation. This create buying pressure when the next IEO project comes.
With that said, I expect COKE will manage to hold the $0.8-0.9 range even if the general market turns south. When the consolidation is over, the COKE price is very possible to soar to $1-1.2, to say the least. Long COKE is very safe play and you can set up stop losses below in case the situation doesn't go as planned.
Be aware that this piece of analysis is NOT financial advice. Always do your own research in crypto investment.
SPXhow expected , we played 4h macd divergence. Now market should connect to down trend again. Huge volatility in this bubble market. Can be only 1 advise - dont trade, or trade with very small position. Dont increase losing position. Only profit position is allowed to increase. look that you bring your stoplos into zero lose/profit area.
NZDUSD DAILY: TARGET 0.6529 DONEAs expected, Target 0.6529 is DONE, ater broke below 0.6864, which Canceled Bullish Outlook.
Break & Hold Below 0.6488,
Bearish Continue,
Potentially Target 0.6382 & 0.6340.
Resistance 0.6529 & 0.6646.
Break Above 0.7034, Buliish Resume, Potentially Testing 0.7218.
Break Above 0.7218, Potentially Testing 0.7316 & 0.7464.
$BA The Long Awaited Long.. BA is currently testing the top of a monthly demand zone. There is a lower zone with daily and weekly gaps below. Both of these zones are centered around the Market Maker Discount Fib zone. Building a Long Position anywhere from here down will be the most epic long awaited long you can ask for. Profit target zone is highlighted up top.
ICICIBANKICICI Bank Limited is an Indian multinational bank and financial services company headquartered in Vadodara. Wikipedia
Customer service: 1860 120 7777
CEO: Sandeep Bakhshi (15 Oct 2018–)
Headquarters: Vadodara
Founder: Industrial Credit and Investment Corporation of India
Founded: 1994, Vadodara
Number of employees: 97,354 (2020)
Subsidiaries: ICICI Lombard, ICICI Securities
XAUUSD, WHILE BELOW 1915 STILL BEARISH TO TARGET 1889 & 1877XAUUSD reversed and turned to neutral after broke 1948.
Then, quickly turned to bearish after broke 1915.
As I said in the previous idea,
"But, if Break below 1915, outlook bearish , open the way to target 1889 & 1877."
Now, XAUUSD still heading to 1889 & 1877.
Strong Support 1877, if break then cancel medium term bullish: medium term outlook neutral.
Break Below 1877, could open the way to target 1853 & 1818.
Resistance at 1915 & 1948.